Erlotinib Hydrochloride

Known as: Erlotinib HCl, Erlotinib Hydrochloride [Chemical/Ingredient], Hydrochloride, Erlotinib 
The hydrochloride salt of a quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds… (More)

Topic mentions per year

Topic mentions per year

2003-2016
02420032016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The purpose of this study was to investigate the site-selective binding of erlotinib hydrochloride (ET), a targeted anticancer… (More)
Is this relevant?
2013
2013
PURPOSE The aim of the present study was to develop a simple and rapid reversed-phase high performance liquid chromatographic… (More)
Is this relevant?
2012
2012
PURPOSE An improved and economical method has been described for the synthesis of erlotinib hydrochloride, as a useful drug in… (More)
  • figure 1
Is this relevant?
2012
2012
Erlotinib hydrochloride (ERLO) belongs to the tyrosine kinase inhibitor family and is used for the treatment of pancreatic… (More)
Is this relevant?
2011
2011
A 43-year-old female was diagnosed with a recurrence of thymoma 6 years after the operation. Eight kinds of systemic chemotherapy… (More)
Is this relevant?
2010
2010
BACKGROUND AND THE PURPOSE OF THE STUDY The binding ability of a drug to serum albumin has influence on the pharmacokinetics of a… (More)
  • figure 1
  • figure 2
  • table 2
  • figure 4
  • figure 5
Is this relevant?
2006
2006
7062 Background: Bevacizumab is a recombinant, humanized anti-VEGF MAb. Erlotinib is a potent, reversible, highly selective and… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Erlotinib is a potent reversible HER1/epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with single-agent… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Bevacizumab (Avastin; Genentech, South San Francisco, CA) is a recombinant, humanized anti-vascular endothelial growth… (More)
Is this relevant?
2005
2005
PURPOSE Erlotinib (Tarceva, OSI-774) is a potent and specific inhibitor of the HER1/epidermal growth factor receptor (EGFR… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?